December 10, 2014

Teva Pharmaceutical Industries on Wednesday announced the launch of generic Celebrex (celecoxib) capsules in the United States. The company is offering the capsules in 50-,100-, 200- and 400-mg dosage strengths. 

 

December 9, 2014

The Generic Pharmaceutical Association agreed to support compromise automatic substitution legislation.

December 9, 2014

Mirixa Corp. announced a partnership with pharmacy system PioneerRx on a patient adherence solution.

December 9, 2014

Reps. Doug Collins, R-Ga., and Dave Loebsack, D-Iowa, introduced on Tuesday H.R. 5815 — the Generic Drug Pricing Fairness Act — which creates greater transparency in how PBMs reimburse pharmacies for generic prescription drugs under Medicare Part D, the military’s TRICARE program, and the Federal Employees Health Benefits Program.

December 9, 2014

From 2009 to 2013, the number of Americans using prescription opiates declined 9.2%, yet both the number of opioid prescriptions filled and the number of days of medication per prescription rose more than 8% in that time period. 

December 9, 2014

Teva Canada, a subsidiary of Teva Pharmaceutical Industries, announced Tuesday that Health Canada has approved its application for the generic version of PrTarceva. 

December 8, 2014

Acura Pharmaceuticals on Monday announced that the company has been issued its first U.S. patent directed at the company's Impede technology and products utilizing that technology. 

December 8, 2014

Fruth Pharmacy, which operates 27 stores in Ohio and West Virginia, has introduced a new program called “Gopher” to the community.

December 8, 2014
Kroger and Medicine Shoppe are participating in MediMergent's pilot study of the National Medication Safety, Outcomes and Adherence Program.
December 8, 2014

The pros of giving healthy women regular low dose aspirin to stave off such serious illness as cancer and heart disease are outweighed by the cons, suggests a large study published online last week in the journal Heart.

December 8, 2014

As Congress continues consideration of the bipartisan conference agreement to the FY 2015 National Defense Authorization Act, National Association of Chain Drug Stores president and CEO Steve Anderson issued a statement.

December 5, 2014

The FDA issued a draft guidance that would provide generic companies a pathway to obtain samples of medicines requiring a Risk Evaluation and Mitigation Strategy (REMS) protocol for product testing.

December 4, 2014

Mylan on Thursday announced that its subsidiary, Mylan Labs, was granted tentative approval from the Food and Drug Administration for two dosages of abacavir/lamivudine tablets for oral suspension. 

December 3, 2014

The Food and Drug Administration published a final rule that sets standards for how information about using medicines during pregnancy and breastfeeding is presented in the labeling of prescription drugs and biological products.

 

December 3, 2014

Health-and-wellness companies see increasing opportunity in the point-of-care channel to reach and engage with patients primed to receive information about their health.

 

December 2, 2014

Perrigo on Tuesday announced that it has received final approval from the Food and Drug Administration on its abbreviated new drug application for diclofenac sodium topical solution 1.5% w/w.

December 2, 2014

Ranbaxy Laboratories on Monday announced the launch of Infimab (BOW015), the first Remicade (Infliximab) biosimilar in India. The product was launched at the Indian Rheumatology Association Conference in Chandigarh.

December 1, 2014

November front-end drug store sales are expected to be comparable to last year while prescriptions dispensed will be up in the low single-digit range, reported Ed Kelly, Credit Suisse research analyst.

 

December 1, 2014

The Food and Drug Administration recently issued draft guidance on key product tracing provisions of the Drug Supply Chain Security Act, which is expected to be implemented by the industry on Jan. 1, 2015. 

November 24, 2014

Perrigo on Monday announced that it has agreed to market the authorized generic version of Astellas U.S.' Protopic ointment 0.1% and 0.03%. 

November 20, 2014

Dr. Reddy’s Labs announced Thursday that it has launched a bioequivalent generic version of Allegra-D 12 Hour Allergy and Congestion, in the U.S. market.

November 20, 2014

The Generic Pharmaceutical Association on Thursday emphasized the savings generic medicines bring to the table in light of rising brand prices. 

November 20, 2014

More specialty drug innovation, greater patient access to medicines and reduced impact from patent expiries will be the primary drivers of an increase in global medicine spending of up to 30% by 2018.

November 20, 2014

The Consumer Healthcare Products Association board of directors on Wednesday announced changes to CHPA’s voluntary guidelines addressing dosing of liquid pediatric over-the-counter medicines.